These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1272356)

  • 1. Letter: Lymphocyte stimulation by acetylcholine receptor in myasthenia gravis.
    Malm TM
    N Engl J Med; 1976 Jul; 295(4):226. PubMed ID: 1272356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenia gravis and acetylcholine receptor].
    Abramsky O; Aharonov A; Tarrab-Hazdai R; Fuchs S
    Harefuah; 1975 Dec; 89(12):553-6. PubMed ID: 815144
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of myasthenia gravis.
    Fulpius BW
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
    Abramsky O; Aharonov A; Webb C; Fuchs S
    Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
    Nishitani H; Noguchi S; Ohta K; Matsubara S
    No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 8. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
    Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
    Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Myasthenia gravis: relationship between serum factor blocking acetylcholine receptors and anti-striated-muscle antibody.
    Ringel SP; Bender AN; Engel WK; Smith HJ
    Lancet; 1975 Jun; 1(7921):1388. PubMed ID: 48981
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
    Richman DP; Patrick J; Arnason BG
    N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
    Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes in myasthenia gravis.
    Barkas T; Boyle RS; Behan PO
    J Clin Lab Immunol; 1981 Jan; 5(1):27-30. PubMed ID: 7218325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis.
    Keesey J; Lindstrom J; Cokely H
    N Engl J Med; 1977 Jan; 296(1):55. PubMed ID: 830279
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.